121 related articles for article (PubMed ID: 37556944)
1. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow.
Schulz AR; Fiebig L; Hirseland H; Diekmann LM; Reinke S; Hardt S; Niedobitek A; Mei HE
EBioMedicine; 2023 Sep; 95():104735. PubMed ID: 37556944
[TBL] [Abstract][Full Text] [Related]
2. Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow.
Ferreira-Gomes M; Chen Y; Durek P; Rincon-Arevalo H; Heinrich F; Bauer L; Szelinski F; Guerra GM; Stefanski AL; Niedobitek A; Wiedemann A; Bondareva M; Ritter J; Lehmann K; Hardt S; Hipfl C; Hein S; Hildt E; Matz M; Mei HE; Cheng Q; Dang VD; Witkowski M; Lino AC; Kruglov A; Melchers F; Perka C; Schrezenmeier EV; Hutloff A; Radbruch A; Dörner T; Mashreghi MF
Nat Commun; 2024 May; 15(1):4182. PubMed ID: 38755157
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC; Lamothe PA; Woodruff MC; Saini AS; Faliti CE; Sanz I; Lee FE
Immunol Rev; 2022 Aug; 309(1):40-63. PubMed ID: 35801537
[TBL] [Abstract][Full Text] [Related]
5. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
Mazzoni A; Vanni A; Spinicci M; Lamacchia G; Kiros ST; Rocca A; Capone M; Di Lauria N; Salvati L; Carnasciali A; Mantengoli E; Farahvachi P; Zammarchi L; Lagi F; Colao MG; Liotta F; Cosmi L; Maggi L; Bartoloni A; Rossolini GM; Annunziato F
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35139036
[TBL] [Abstract][Full Text] [Related]
7. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.
Prabhakaran M; Matassoli F; Leggat D; Hoover A; Srikanth A; Wu W; Henry AR; Wang J; Lin BC; Teng IT; Schramm CA; Castro M; Serebryannyy L; Jean-Baptiste N; Moore C; Gajjala S; Todd JM; McCarthy E; Narpala S; Francica J; Program VP; Corbett-Helaire KS; Douek DC; Kwong PD; Seder RA; Andrews SF; McDermott AB
Sci Transl Med; 2024 Jan; 16(728):eadd5960. PubMed ID: 38170789
[TBL] [Abstract][Full Text] [Related]
8. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
Front Immunol; 2021; 12():726960. PubMed ID: 34671348
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
Turner JS; Kim W; Kalaidina E; Goss CW; Rauseo AM; Schmitz AJ; Hansen L; Haile A; Klebert MK; Pusic I; O'Halloran JA; Presti RM; Ellebedy AH
Nature; 2021 Jul; 595(7867):421-425. PubMed ID: 34030176
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
Mrak D; Tobudic S; Koblischke M; Graninger M; Radner H; Sieghart D; Hofer P; Perkmann T; Haslacher H; Thalhammer R; Winkler S; Blüml S; Stiasny K; Aberle JH; Smolen JS; Heinz LX; Aletaha D; Bonelli M
Ann Rheum Dis; 2021 Oct; 80(10):1345-1350. PubMed ID: 34285048
[TBL] [Abstract][Full Text] [Related]
11. Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab.
Nytrova P; Stastna D; Tesar A; Menkyova I; Posova H; Koprivova H; Mikulova V; Hrdy J; Smela G; Horakova D; Rysankova I; Doleckova K; Tyblova M
Front Immunol; 2023; 14():1149629. PubMed ID: 37398654
[TBL] [Abstract][Full Text] [Related]
12. A unique population of IgG-expressing plasma cells lacking CD19 is enriched in human bone marrow.
Mei HE; Wirries I; Frölich D; Brisslert M; Giesecke C; Grün JR; Alexander T; Schmidt S; Luda K; Kühl AA; Engelmann R; Dürr M; Scheel T; Bokarewa M; Perka C; Radbruch A; Dörner T
Blood; 2015 Mar; 125(11):1739-48. PubMed ID: 25573986
[TBL] [Abstract][Full Text] [Related]
13. Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers.
Oliveira-Silva J; Reis T; Lopes C; Batista-Silva R; Ribeiro R; Marques G; Pacheco V; Rodrigues T; Afonso A; Pinheiro V; Araújo L; Rodrigues F; Antunes I
Vaccine; 2022 Jan; 40(4):650-655. PubMed ID: 34952755
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
15. The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.
Bilgin H; Marku M; Yilmaz SS; Karahasan Yagci A; Sili U; Can B; Can Sarinoglu R; Mulazimoglu Durmusoglu L; Haklar G; Sirikci O; Eksioglu Demiralp E
Vaccine; 2022 Apr; 40(18):2619-2625. PubMed ID: 35339303
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals.
Fraley E; LeMaster C; Geanes E; Banerjee D; Khanal S; Grundberg E; Selvarangan R; Bradley T
BMC Med; 2021 Jul; 19(1):169. PubMed ID: 34304742
[TBL] [Abstract][Full Text] [Related]
17. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
18. One-Year Sustained Cellular and Humoral Immunities in Coronavirus Disease 2019 (COVID-19) Convalescents.
Zhang J; Lin H; Ye B; Zhao M; Zhan J; Dong S; Guo Y; Zhao Y; Li M; Liu S; Zhang H; Xiao W; Guo Y; Yue C; Zhang D; Yang M; Zhang J; Quan C; Shi W; Liu X; Liu P; Jiang Y; Wu G; Gao GF; Liu WJ
Clin Infect Dis; 2022 Aug; 75(1):e1072-e1081. PubMed ID: 34609506
[TBL] [Abstract][Full Text] [Related]
19. Persistent but atypical germinal center reaction among 3
Stefanski AL; Rincon-Arevalo H; Schrezenmeier E; Karberg K; Szelinski F; Ritter J; Chen Y; Meisel C; Jahrsdörfer B; Ludwig C; Schrezenmeier H; Lino AC; Dörner T
Front Immunol; 2022; 13():943476. PubMed ID: 36032111
[TBL] [Abstract][Full Text] [Related]
20. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
Scaggs Huang F
J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
